Sign Up to like & get
recommendations!
1
Published in 2022 at "Transplantation"
DOI: 10.1097/tp.0000000000004425
Abstract: BACKGROUND Liver transplantation (LT) is the treatment of choice for patients with hepatocellular carcinoma (HCC). Recurrence of HCC after LT occurs in 10% to 20% of cases. Preclinical studies to evaluate immune checkpoint inhibitors in…
read more here.
Keywords:
pd1 blockade;
hcc;
transplantation;
treatment ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2020 at "Journal for ImmunoTherapy of Cancer"
DOI: 10.1136/jitc-2020-sitc2020.0546
Abstract: Background Non small cell lung cancer is one of the cancer types where Immune checkpoint blockade has demonstrated unprecedented clinical efficiency. However, only a fraction of patients benefit from such therapy; factors determining this response…
read more here.
Keywords:
pd1;
status;
cd8 cells;
pd1 blockade ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2025 at "Biomarker Research"
DOI: 10.1186/s40364-025-00726-w
Abstract: Oncolytic viruses (OVs) are increasingly recognized as promising tools for cancer therapy, as they selectively infect and destroy tumor cells while leaving healthy cells unharmed. Despite considerable progress, the limited therapeutic efficacy of OV-based virotherapy…
read more here.
Keywords:
virotherapy;
panoptosis;
pd1 blockade;
cell ... See more keywords
Sign Up to like & get
recommendations!
3
Published in 2022 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2022.847350
Abstract: In the past few decades, immunotherapy has emerged as one of the most promising strategies among current treatments of cancer. In particular, the field of PD1/PD-L1 inhibitors has been boosted, widely applied into clinical practice…
read more here.
Keywords:
pd1 blockade;
blockade therapy;
pd1;
efficacy ... See more keywords